Novo Nordisk Invest 4 A/S — Credit Rating and Financial Key Figures

Novo Nordisk Invest 4 A/S (CVR number: 31853923) is a company from GLADSAXE. The company recorded a gross profit of -55 kDKK in 2024. The operating profit was -110 kDKK, while net earnings were 7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -2.6 %, which can be considered poor but Return on Equity (ROE) was 0.4 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 97.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Novo Nordisk Invest 4 A/S's liquidity measured by quick ratio was 36.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.